Literature DB >> 3130493

A single point mutation has pleiotropic effects on pp60v-src function.

M J Welham1, J A Wyke.   

Abstract

The Rous sarcoma virus mutant tsLA29 encodes a pp60v-src molecule that is temperature sensitive for both tyrosine kinase activity and its ability to locate at the cell periphery. The defect in localization appears to be due to a perturbation in events following complex dissociation, since the mutant enzyme shows a rapidly reversible association with the cytoskeleton when shifted between permissive and restrictive temperatures. Although tsLA29 pp60v-src differs from the wild type at three amino acid residues, studies with chimeric proteins show that only one of the mutations, an alanine-for-proline substitution at residue 507, accounts for all the temperature-sensitive characteristics. Moreover, a single second site mutation, at residue 427, can restore the wild phenotype. Cells infected with a chimeric virus encoding only the alanine substitution at position 507 have a conspicuously fusiform morphology, suggesting that this mutation also has subtle effects on pp60v-src function that are apparently compensated for by the other mutations in native tsLA29.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3130493      PMCID: PMC253272     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Reversion of temperature sensitive transformation mutants of Rous sarcoma virus and its effect on the expression of tumour specific surface antigen.

Authors:  J A Wyke; R Kurth
Journal:  J Gen Virol       Date:  1978-09       Impact factor: 3.891

2.  Protein kinase activity associated with the avian sarcoma virus src gene product.

Authors:  M S Collett; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

3.  Identification of a polypeptide encoded by the avian sarcoma virus src gene.

Authors:  A F Purchio; E Erikson; J S Brugge; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

4.  Evidence that the src gene product of Rous sarcoma virus is membrane associated.

Authors:  J G Krueger; E Wang; A R Goldberg
Journal:  Virology       Date:  1980-02       Impact factor: 3.616

5.  A mutant of Rous sarcoma virus with a thermolabile defect in the virus envelope.

Authors:  F Tato; J A Beamand; J A Wyke
Journal:  Virology       Date:  1978-07-01       Impact factor: 3.616

Review 6.  Empirical predictions of protein conformation.

Authors:  P Y Chou; G D Fasman
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

7.  Complementation of transforming functions by temperature-sensitive mutants of avian sarcoma virus.

Authors:  J A Wyke
Journal:  Virology       Date:  1973-07       Impact factor: 3.616

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  Antibodies against synthetic peptides as a tool for functional analysis of the transforming protein pp60src.

Authors:  T Tamura; H Bauer; C Birr; R Pipkorn
Journal:  Cell       Date:  1983-09       Impact factor: 41.582

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  19 in total

1.  The SH3 domain directs acto-myosin-dependent targeting of v-Src to focal adhesions via phosphatidylinositol 3-kinase.

Authors:  V J Fincham; V G Brunton; M C Frame
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase-activating protein.

Authors:  V Duronio; M J Welham; S Abraham; P Dryden; J W Schrader
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

3.  Glycoprotein tyrosine phosphorylation in Rous sarcoma virus-transformed chicken embryo fibroblasts.

Authors:  L M Kozma; A B Reynolds; M J Weber
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

4.  The catalytic activity of Src is dispensable for translocation to focal adhesions but controls the turnover of these structures during cell motility.

Authors:  V J Fincham; M C Frame
Journal:  EMBO J       Date:  1998-01-02       Impact factor: 11.598

5.  Selective response of ternary complex factor Sap1a to different mitogen-activated protein kinase subgroups.

Authors:  T Strahl; H Gille; P E Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

6.  Partial reversion of conditional transformation correlates with a decrease in the sensitivity of rat cells to killing by the parvovirus minute virus of mice but not in their capacity for virus production: effect of a temperature-sensitive v-src oncogene.

Authors:  N Salome; B van Hille; M Geuskens; J Rommelaere
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

7.  Active ERK/MAP kinase is targeted to newly forming cell-matrix adhesions by integrin engagement and v-Src.

Authors:  V J Fincham; M James; M C Frame; S J Winder
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

8.  Mutations in v-Src SH3 and catalytic domains that jointly confer temperature-sensitive transformation with minimal temperature-dependent changes in cellular tyrosine phosphorylation.

Authors:  A D Catling; V J Fincham; M C Frame; B Haefner; J A Wyke
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

9.  Ala-->Gly mutation in the putative catalytic loop confers temperature sensitivity on Ros, insulin receptor, and insulin-like growth factor I receptor protein-tyrosine kinases.

Authors:  J Chen; T Hanafusa; L H Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

10.  SRC-mediated phosphorylation of focal adhesion kinase couples actin and adhesion dynamics to survival signaling.

Authors:  M A Westhoff; B Serrels; V J Fincham; M C Frame; N O Carragher
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.